Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.900

-4.3%

Dec 19 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hope who wrote (9585)	7/1/1998 2:06:00 PM
From: dowman	Read Replies (2) of 14328

No Hope, not long Abbott as this is not a major issue to Abt, as it would be to smaller companies. And if the facts happen to be negative that does not make them wrong. I am looking for some real reasons and new information. If there is none available so be it. But I also will continue to respond. I also have been around this area for a while, and know a fair amount. For instance, Salv was considered by many in the medical field to have the best test around. A lot of good it did them with poor management. They will not make it. Epitope had the same problem. Incredibly bad management. They are trying to introduce other uses for their product. Jury still out, but the clock is ticking. As for Caly, they are just too late to the party, and have no other products. Even Triby seems to have dropped the idea of a urine rapid test, as I have not heard them mention the "agreement" signed a year or so ago. And as I agree that two years in the future that a rapid format is likely to be the dominant testing format, anyone without will be history.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next